This biotech is working on a GLP-1 pill that could be better than the Wegovy version
This experimental pill helped people lose about 16% of their body weight after about a year of treatment
AI-powered media bias analysis by Daily Composite
Based on analysis of recent MarketWatch articles using Claude, GPT-4o, Gemini, and Grok. Scores reflect framing and presentation, not factual accuracy.
Learn about our methodology →According to Daily Composite AI analysis of recent MarketWatch articles, the outlet scores pending — placing it in the Unrated category.
This rating is generated by four independent AI models (Claude, GPT-4o, Gemini, and Grok) analyzing word choice, framing, sources cited, and emotional language in recent articles. The consensus score reduces single-model bias.
This experimental pill helped people lose about 16% of their body weight after about a year of treatment
The outlook for the U.S. economy will continue to darken as long as the Strait of Hormuz remains effectively closed to oil-tanker traffic, even though the U.S. now produces about as much oil and natural gas as it consumes.
It probably helps that Wall Street analysts have continued to raise their earnings forecasts, according to Ed Yardeni, founder of Yardeni Research.
“The issue is not the weather, high insurance premiums or high maintenance fees.”
A BTIG analyst sees 55% more upside for Upstart’s stock, saying the fintech company’s plan to obtain a banking charter could reduce its risky exposure to private credit.
If you need any further evidence of the wisdom of holding some energy stocks in your 401(k) and other retirement accounts, look at Berkshire Hathaway.
You don’t have to lose everything — not your savings or your wits — when you become a caregiver.